After graduating from school, Dr. Otomo went abroad to Germany to study at the Max Planck Institute of Biochemistry and learned advanced gene-related technologies there. After returning to Japan, he continued basic scientific research as a first generation fellow researcher under the basic science fellowship system of Riken. After that, Dr. Otomo joined Hitachi, Inc. and was assigned to be a researcher at the Center for Exploratory Research, engaged in research for the Japan Science and Technology Agency (JST) for Sakigake research. Further, he took charge of the launch of new life science businesses. After that, Dr. Otomo temporarily transferred to the New Energy and Industrial Technology Development Organization (NEDO), taking charge of matters such as research funding.
At the Smart Life Business Management Division of Hitachi, Inc., he is currently in charge of launching the regenerative medicine business. From April 2018, he has been working as a theme leader for the promotion of "Industrial Utilization of iPS Cells" at the COCN (Council on Competitiveness-Nippon), where he is managing the development of recommendations. He is also currently serving as the Chair of the Supporting Industries Committee of the Forum for Innovative Regenerative Medicine (FIRM). He holds a Ph.D.

What I expect of LINK-J

I expect LINK-J to actively promote the creation of innovation by serving as a mediator between venture companies and large companies.

Message to LINK-J Special Members

I expect LINK-J to actively promote interaction with supporters.